[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial

Volume: 10, Issue: 1
Published: Oct 15, 2020
Abstract
Introduction This is a prospective, single-center trial in pediatric patients with sarcoma aiming to evaluate [ 18 F]FDG PET/CT as a tool for early response assessment to neoadjuvant chemotherapy (neo-CTX). Methods Bone or soft tissue sarcoma patients with (1) baseline [ 18 F]FDG PET/CT within 4 weeks prior to the start of neo-CTX (PET1), (2) early interim [ 18 F]FDG PET/CT (6 weeks after the start of neo-CTX (PET2), (3) evaluation of neo-CTX...
Paper Details
Title
[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
Published Date
Oct 15, 2020
Volume
10
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.